Fluorescence cystoscopy: is flexible scope as effective as rigid?

A. Zlotta

DOI: https://doi.org/10.1016/J.EURURO.2004.10.026

IF: 24.267

2005-03-01

European Urology

Abstract:

What problem does this paper attempt to address?

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Leli Zeng,Yu Chen,Jiangping Liu,Huaiyi Huang,Ruilin Guan,Liangnian Ji,Hui Chao

DOI: https://doi.org/10.1038/srep19449

IF: 4.6

2016-01-14

Scientific Reports

Abstract:AbstractCisplatin was the first metal-based therapeutic agent approved for the treatment of human cancers, but its clinical activity is greatly limited by tumor drug resistance. This work utilized the parent complex [Ru(phen)2(PIP)]2+ (1) to develop three Ru(II) complexes (2–4) with different positional modifications. These compounds exhibited similar or superior cytotoxicities compared to cisplatin in HeLa, A549 and multidrug-resistant (A549R) tumor cell lines. Complex 4, the most potent member of the series, was highly active against A549R cancer cells (IC50 = 0.8 μM). This complex exhibited 178-fold better activity than cisplatin (IC50 = 142.5 μM) in A549R cells. 3D multicellular A549R tumor spheroids were also used to confirm the high proliferative and cytotoxic activity of complex 4. Complex 4 had the greatest cellular uptake and had a tendency to accumulate in the mitochondria of A549R cells. Further mechanistic studies showed that complex 4 induced A549R cell apoptosis via inhibition of thioredoxin reductase (TrxR), elevated intracellular ROS levels, mitochondrial dysfunction and cell cycle arrest, making it an outstanding candidate for overcoming cisplatin resistance.

multidisciplinary sciences
Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes

Zhang Yan,Yang Yan,Wen Yan-Zhen,Jia Shi-Fang

DOI: https://doi.org/10.11862/CJIC.2017.123

2017-01-01

Chinese journal of inorganic chemistry

Abstract:Three new mononuclear ruthenium complexes [Ru(bpy)(2)(paH)]PF6(1), [Ru(dmb)(2)(paH)]PF6(2) and [Ru(phen)(2) (paH)]PF6 (3) (bpy =2,2'-bipyridine,dmb =4,4'-dimethyl-2,2'-bipyridine, phen =phenanthroline, paH = pyridinecarboxylic acid) were synthesized and characterized using elemental analysis, infrared, nuclear magnetic spectroscopy and electrospray ionization mass spectrometry.Their photophysical and electrochemical properties were also studied. The complexes 1 similar to 3 undergo metal centered oxidation and the Ru(II)/Ru(III) redox couple peak are in 0.7 similar to 4.0 V versus a saturated calomel electrode. The cytotoxicity of these complexes in vitro was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide(MTT) assay. The results indicated that 1 similar to 3 exhibited significant dose-dependent cytotoxicity to human breast cancer (MCF-7), gastric cancer (AGS) and lung cancer (A549) tumour cell lines. It is worth noting that 2 showed excellent antitumor effects in a cellular study (IC50 value of 2.85 mu mol.L-1 for human breast cancer cells in vitro).
Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes

Guang-Bin Jiang,Wen-Yao Zhang,Miao He,Yi-Ying Gu,Lan Bai,Yang-Jie Wang,Qiao-Yan Yi,Fan Du

DOI: https://doi.org/10.1016/j.jinorgbio.2021.111616

IF: 4.336

2021-12-01

Journal of Inorganic Biochemistry

Abstract:Ruthenium-containing complexes have emerged as good alternative to the currently used platinum-containing drugs for malignant tumor therapy. In this work, cytotoxic effects of recently synthesized ruthenium polypyridyl complexes [Ru(bpy)2(CFPIP)](ClO4)2 (bpy = 2,2′-bipyridine, CFPIP = (E)-2-(4-fluorostyryl)-1H-imidazo[4,5-f][1,10]phenanthroline, Ru(II)-1), [Ru(phen)2(CFPIP)](ClO4)2 (phen = 1,10-phenanthroline, Ru(II)-2) and [Ru(dmb)2(CFPIP)](ClO4)2 (dmb = 4,4′-dimethyl-2,2′-bipyridine, Ru(II)-3) toward different tumor cells were investigated in vitro and compared with cisplatin, the most widely used chemotherapeutic drug against hepatocellular carcinoma (HepG-2). The results demonstrate that target complexes show excellent cytotoxicity against HepG-2 cells with low IC50 value of 21.4 ± 1.5, 18.0 ± 2.1 and 22.3 ± 1.7 μM, respectively. It was important noting that target Ru(II) complexes exhibited better antitumor activity than cisplatin (IC50 = 28.5 ± 2.4 μM) against HepG-2 cells, and has no obvious toxicity to normal cell LO2. DNA binding results suggest that Ru(II)-1, Ru(II)-2 and Ru(II)-3 interact with CT DNA (calf thymus DNA) through intercalative mode. Complexes exerted its antitumor activity through increasing anti-migration and inducing cell cycle arrest at the S phase. In addition, the apoptosis was tested by AO (acridine orange)/EB (ethidium bromide) staining and flow cytometry. Mitochondrial membrane potential (MMP), reactive oxygen species (ROS), and colocalization tests were also evaluated by ImageXpress Micro XLS system. Overall, the results show that the ruthenium polypyridyl complexes induce apoptosis in HepG-2 cells through ROS-mediated mitochondria dysfunction pathway.

biochemistry & molecular biology,chemistry, inorganic & nuclear
Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties

Afroditi Kokkosi,Elpida Garofallidou,Nikolaos Zacharopoulos,Nikolaos Tsoureas,Konstantina Diamanti,Nikolaos S Thomaidis,Antigoni Cheilari,Christina Machalia,Evangelia Emmanouilidou,Athanassios I Philippopoulos

DOI: https://doi.org/10.3390/molecules29133215

IF: 4.6

2024-07-06

Molecules

Abstract:Organometallic complexes of the formula [Ru(N^N)(p-cymene)Cl][X] (N^N = bidentate polypyridyl ligands, p-cymene = 1-methyl-4-(1-methylethyl)-benzene, X = counter anion), are currently studied as possible candidates for the potential treatment of cancer. Searching for new organometallic compounds with good to moderate cytotoxic activities, a series of mononuclear water-soluble ruthenium(II)-arene complexes incorporating substituted pyridine-quinoline ligands, with pending -CH2OH, -CO2H and -CO2Me groups in the 4-position of quinoline ring, were synthesized, for the first time, to study their possible effect to modulate the activity of the ruthenium p-cymene complexes. These include the [Ru(η6-p-cymene)(pqhyme)Cl][X] (X = Cl- (1-Cl), PF6- (1-PF6), pqhyme = 4-hydroxymethyl-2-(pyridin-2-yl)quinoline), [Ru(η6-p-cymene)(pqca)Cl][Cl] ((2-Cl), pqca = 4-carboxy-2-(pyridin-2-yl)quinoline), and [Ru(η6-p-cymene)(pqcame)Cl][X] (X = Cl- (3-Cl), PF6- (3-PF6), pqcame = 4-carboxymethyl-2-(pyridin-2-yl)quinoline) complexes, respectively. Identification of the complexes was based on multinuclear NMR and ATR-IR spectroscopic methods, elemental analysis, conductivity measurements, UV-Vis spectroscopic, and ESI-HRMS techniques. The solid-state structures of 1-PF6 and 3-PF6 have been elucidated by single-crystal X-ray diffraction revealing a three-legged piano stool geometry. This is the first time that the in vitro cytotoxic activities of these complexes are studied. These were conducted in HEK293T (human embryonic kidney cells) and HeLa cells (cervical cancer cells) via the MTT assay. The results show poor in vitro anticancer activities for the HeLa cancer cell lines and 3-Cl proved to be the most potent (IC50 > 80 μΜ). In both cell lines, the cytotoxicity of the ligand precursor pqhyme is significantly higher than that of cisplatin.
New organoruthenium compounds with pyrido[2′,3′:5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action

Marijana Pavlović,Stefan Nikolić,Nevenka Gligorijević,Biljana Dojčinović,Sandra Aranđelović,Sanja Grgurić-Šipka,Siniša Radulović

DOI: https://doi.org/10.1007/s00775-019-01647-4

2019-02-14

JBIC Journal of Biological Inorganic Chemistry

Abstract:Three new ruthenium(II)-arene complexes with pyrido[2′,3′:5,6]pyrazino[2,3-f][1, 10]phenanthroline (ppf) of general formula: C1 ([(ƞ6-benzene)Ru(ppf)Cl]PF6, C2 ([(ƞ6-toluene)Ru(ppf)Cl]PF6) and C3 ([(ƞ6-p-cymene)Ru(ppf)Cl]PF6) have been synthesized. The structures of complexes were determined by elemental analysis, IR, ESI–MS, as well as with 1H and 13C NMR spectroscopy. Cytotoxic activity has been evaluated in three different human neoplastic cell lines (A549, A375, LS 174T) and in one human non-tumor cell line (MRC-5), by the MTT assay. Complexes C1–C3 showed IC50 values in the micromolar range below 100 µM. Complex C3, carrying ƞ6-p-cymene as the arene ligand, exhibited cytoselective activity toward human malignant melanoma A375 cells (IC50 = 15.8 ± 2.7 µM), and has been selected for further analyses of its biological effects. Drug-accumulation study performed in the A375 cells disclosed that C3 possess lower ability of entering the cells compared to cisplatin and distributes approximately equally in the cytosol and membrane/organelle fraction of cells. Investigations in the 3D model of A375 cells, disclosed different effects of the complex C3 and cisplatin on growth of multicellular tumor spheroids (MCTSs). While the size of cisplatin-treated MCTSs decreased with time, MCTSs treated with C3 continued to growth. Differences in structural organization and biological activity of this type of ruthenium(II)-arene complexes versus cisplatin in A375 malignant melanoma cells pointed out their different modes of action, and necessity for further biological studies and optimizations for potential applications.Graphical abstract
Phenanthrene Appending Ruthenium Complexes: DNA Binding, Molecular Docking, TDDFT Calculation, and Photocytoxicity In Vitro

Xue‐Wen Liu,Liang Ma,Geng‐Jun He,Xia Hu,Yuan‐Dao Chen,Jun‐Ling Jin,Song‐Bai Zhang

DOI: https://doi.org/10.1002/aoc.7735

IF: 3.9

2024-09-02

Applied Organometallic Chemistry

Abstract:The Ru(II) complexes were obtained by introducing a new ligand containing phenanthrene moiety. Two complexes displayed obvious photocytotoxicity and low dark cytotoxicity towards Hela, A549, and A375 cells. Two complexes might exhibit PDT activities via type II mechanism from TDDFT results. Photodynamic therapy (PDT) has been an effective tumor treatment to reduce the side effects of chemotherapy. Herein, we described the synthesis of two Ru (II) complexes by introducing a phenanthrene unit and their photocytotoxicity. Ru1 and Ru2 displayed high DNA affinities by intercalation. Under light, two complexes produced high singlet oxygen (1O2) quantum yields and cleaved DNA efficiently. Both high DNA affinities and 1O2 quantum yields of two complexes resulted in obvious photocytotoxicity towards Hela, A549, and A375 cells. Furthermore, low dark cytotoxicity was also observed for two complexes, which may promote them to act as potential PDT agents. TDDFT (Time‐dependent density functional theory) calculations also demonstrated two complexes that might display the PDT activities via 1O2 photogeneration.

chemistry, inorganic & nuclear, applied
Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Hong-Liang Huang,Bing Tang,Qiao-Yan Yi,Dan Wan,Lin-Lin Yang,Yun-Jun Liu

DOI: https://doi.org/10.1007/s11243-018-0264-y

2018-07-24

Transition Metal Chemistry

Abstract:Five new ruthenium(II) polypyridyl complexes [Ru(N–N)2(BTCP)](ClO4)2 (BTCP = 2-(bicyclo[2.2.1]hept-5-en-2-yl)-1H-imidazo[4,5-f][1,10]phenanthroline; N–N = dmb: 4,4′-dimethyl-2,2′-bipyridine, 1; bpy: 2,2′-bipyridine 2; ttbpy: ditertairy-butyl-2,2′-bipyridine 3; phen: 1,10-phenanthroline 4; dmp: 2,9-dimethyl-1,10-phenanthroline 5) were synthesized and characterized by elemental analysis, IR, ESI-MS, 1H NMR and 13C NMR. The DNA-binding behaviors were studied by electronic absorption titration, viscosity measurements and molecular docking. The results show that complexes 1–4 interact with CT-DNA through intercalative modes, whereas complex 5 interacts through a partial intercalative mode. The DNA-binding constants follow the order of 3 > 4 > 1 > 2 > 5. The cytotoxic activity of the complexes against SGC-7901, PC-12, SiHa, HepG2, BEL-7402, A549 and HeLa cancer cell lines was evaluated by MTT method. The complexes display moderate cytotoxic activity toward BEL-7402 cells with an IC50 value of 25.5 ± 1.3 µM for 1, 45.7 ± 4.2 µM for 2, 6.5 ± 0.4 µM for 3, 13.2 ± 1.2 µM for 4 and 9.1 ± 1.1 µM for 5, respectively. Complex 5 exhibits the highest cytotoxic effect on the cell growth in SGC-7901, HepG2 and A549 cells among the complexes. The cytotoxic activity of the complexes is not consistent with the order of their DNA-binding constants. The apoptosis of BEL-7402 cells was studied under a fluorescent microscope and by flow cytometry. Measurements of reactive oxygen species, mitochondrial membrane potential and comet assays were carried out. The cell cycle arrest was investigated by flow cytometry, and the results demonstrate that complexes 1, 2, 4 and 5 inhibit the cell growth at G0/G1 phase and complex 3 induces cell cycle arrest at G2/M phase in BEL-7402 cells. The expression of Bcl-2 family induced by the complexes was studied by western blot. The results obtained show that complexes induce apoptosis in BEL-7402 cells through action of DNA and ROS-mediated mitochondrial dysfunction pathways.

chemistry, inorganic & nuclear
Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes

Ye-Hong Dou,Shou-De Xu,Yi Chen,Xiang-Hua Wu

DOI: https://doi.org/10.1080/10426507.2017.1359594

2017-09-05

Abstract:Twelve arene and cyclopentadienyl ruthenium(II) dithiocarbamate complexes have been prepared and characterized by spectroscopic methods. The structures of 3a and 3c have been determined by X-ray crystallography. Their in vitro antitumor activities were evaluated by MTT method against four tumor cells (SKOV-3, HepG-2, A549, as well as PC12) and two murine cells (RAW246.7 and L6). Notably, the results in vitro indicated that the arene ruthenium(II) complex 3e (N-methyl piperazine) displayed the highest activity and selectivity towards cancer HepG-2 cells.
Synthesis, DNA Binding Mode, Singlet Oxygen Photogeneration and DNA Photocleavage Activity of Ruthenium Compounds with Porphyrin-Imidazo[4,5-f ]phenanthroline Conjugated Ligand

Jun Jiang,Dan Liu,Yimei Zhao,Fengshou Wu,Ke Yang,Kai Wang

DOI: https://doi.org/10.1002/aoc.4468

IF: 3.9

2018-01-01

Applied Organometallic Chemistry

Abstract:Using 1,10‐phenanothroline‐5,6‐dione and 10,20‐bis(4‐methylphenyl)porphyrin copper as starting materials, a conjugated porphyrin–imidazo[4,5‐f]‐1,10‐phenanothroline ligand (Por 1) was prepared. Subsequently, the copper complex of Por 1 was reacted with Ru(1,10‐phenanothroline)2Cl2 to yield ruthenium compound Por 2. After removal of copper metal under acid condition, the free base porphyrin of Por 2 (Por 3) was prepared. The structure of these compounds was confirmed using UV–visible, 1H NMR, mass and infrared spectroscopies and elemental analysis. Through UV–visible, fluorescence and circular dichroism analyses, the interaction modes between Por 1–3 and calf thymus DNA were investigated. Por 1 interacted with DNA via outside groove face, but Por 2 and Por 3 showed intercalative interaction with DNA. Binding constants between Por 1–3 and DNA were 7.79 × 105, 1.29 × 106 and 1.32 × 106 M−1, respectively. With 5,10,15,20‐tetraphenylporphyrin (H2TPP) as a control, the singlet oxygen (1O2) generation of Por 1–3 was measured using the 1,3‐diphenylisobenzofuran method. The 1O2 generation rate of Por 1–3 followed the order: Por 3 >Por 1 >H2TPPP >Por 2. Por 1 and Por 3 showed better 1O2 quantum yields than Por 2, which were almost threefold higher than that of H2TPP. The DNA cleavage ability of Por 1–3 was analyzed using gel electrophoresis. Por 3 showed higher DNA photocleavage activity, with more than 50% photocleavage rate at 20 μM. These results suggest that amphipathic (hydrophilic/lipophilic) Por 3 with conjugated Por 1 ligand is a potential photosensitizer in cancer therapy.
Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds

Xia Hu,Ning-Yi Liu,Yuan-Qing Deng,Shan Wang,Ting Liu,Xue-Wen Liu

DOI: https://doi.org/10.3390/molecules26113471

IF: 4.6

2021-06-07

Molecules

Abstract:The photophysical and biological properties of two new phenanthroline-based ligand ruthenium complexes were investigated in detail. Their DNA interaction modes were determined to be the intercalation mode using spectra titration and viscosity measurements. Under irradiation, obvious photo-reduced DNA cleavages were observed in the two complexes via singlet oxygen generation. Furthermore, complex 2 showed higher DNA affinity, photocleavage activity, and singlet oxygen quantum yields than complex 1. The two complexes showed no toxicity towards tumor cells (HeLa, A549, and A375) in the dark. However, obvious photocytotoxicities were observed in the two complexes. Complex 2 exhibited large PIs (phototherapeutic indices) (ca. 400) towards HeLa cells. The study suggests that these complexes may act as DNA intercalators, DNA photocleavers, and photocytotoxic agents.

chemistry, multidisciplinary,biochemistry & molecular biology
DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes

Xia Hu,Qian Luo,Yao Qin,Yao Wu,Xue-Wen Liu

DOI: https://doi.org/10.3390/molecules27123676

IF: 4.6

2022-06-08

Molecules

Abstract:With the development of metal-based drugs, Ru(II) compounds present potential applications of PDT (photodynamic therapy) and anticancer reagents. We herein synthesized two naphthyl-appended ruthenium complexes by the combination of the ligand with naphthyl and bipyridyl. The DNA affinities, photocleavage abilities, and photocytotoxicity were studied by various spectral methods, viscosity measurement, theoretical computation method, gel electrophoresis, and MTT method. Two complexes exhibited strong interaction with calf thymus DNA by intercalation. Production of singlet oxygen (1O2) led to obvious DNA photocleavage activities of two complexes under 365 nm light. Furthermore, two complexes displayed obvious photocytotoxicity and low dark cytotoxicity towards Hela, A549, and A375 cells.
High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection.

F. Marfil,V. Pineau,A. Sioufi,J. Godbillon

DOI: https://doi.org/10.1016/0378-4347(96)00118-1

1996-08-30

Abstract:
Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Sundarraman Balaji,Mohamed Kasim Mohamed Subarkhan,Gunasekaran Balamurugan,Rengan Ramesh

DOI: https://doi.org/10.1002/aoc.7574

IF: 3.9

2024-06-02

Applied Organometallic Chemistry

Abstract:Three new dinuclear arene Ru(II) complexes containing arylthiourea ligands were synthesized and characterized. The complexes significantly inhibited the cancer cell proliferation and persuaded a programmed cell death (apoptosis) in human cancer cells. New half‐sandwich dinuclear arene ruthenium complexes of the general formula [(η6‐p‐cymene)Ru(k2‐S‐arylthiourea)Cl] (1–3) have been synthesized. The structural characterization of the ruthenium complexes has been established using analytical and various spectroscopic techniques. The bidentate coordination of the ligands and pseudo‐octahedral geometry around the ruthenium(II) ion are confirmed by the single‐crystal X‐ray diffraction technique. In vitro antiproliferative activity of the complexes has been studied by MTT (3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5 diphenyl tetrazolium bromide) assay against lung (A549), breast (MCF‐7), cervical (HeLa), ovarian (A2780) cancer cells, and non‐cancerous NIH‐3T3 mouse embryonic fibroblast cells. The results show that all the complexes exhibit excellent cytotoxicity towards all the cancer cells, with a low IC50 concentration compared with cisplatin. Further, the mode of cancer cell death has been examined by AO–EB (acridine orange/ethidium bromide), and DAPI (4',6‐diamidino‐2‐phenylindole) staining studies demonstrate the apoptosis‐associated cell morphological changes. Furthermore, the quantitative differentiation of late apoptosis has been elucidated by flow cytometry employing dual staining of Annexin V‐FITC and propidium iodide, which involves the transfer of phosphatidylserine to the external leaflet of the cytoplasmic membrane.

chemistry, inorganic & nuclear, applied
Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Yanjing Yang,Lihua Guo,Jie Huang,Mingjun Ji,Xingxing Ge,Wenjing Chen,Huanxing Zhou,Xin Li,Shujing Tuo,Zhe Liu

DOI: https://doi.org/10.1016/j.dyepig.2020.108867

IF: 5.122

2021-01-01

Dyes and Pigments

Abstract:A series of unsaturated (16-electron) five-coordinated ruthenium (II) complexes of the type [(η6-arene)Ru(N^N)]+PF6−, where N^N is aminoimine and η6-arene is benzene (bz) (Ru1), 3-phenylpropan-1-ol (bz-PA) (Ru2), or 4-phenylbutan-1-ol (bz-BA) (Ru3), respectively, have been serendipitously synthesized via solvent (methanol)-involved rearrangement. The identity and purity of these new complexes were determined by NMR spectroscopy, elemental analysis, mass spectrometry, and X-ray crystallography techniques. Their fluorescence property and electrochemical behavior were also investigated. These complexes showed sufficient stability and exhibited higher anticancer activity toward A549 human lung cancer cells, human cervical carcinoma cells (HeLa) and hepatocellular carcinoma cell (HepG2) than cisplatin. The investigation of structure-activity relationship displayed that Ru1 with the hydrophobic groups exhibited enhanced anticancer activity in comparison to Ru2 and Ru3 containing hydroxyl groups. Notably, complex Ru1 entered A549 human lung cancer cells through a non-energy-dependent pathway and mainly accumulated in lysosomes. Moreover, Ru1 induced a dose-dependent apoptosis and sub-G1 fraction perturbation.

engineering, chemical,chemistry, applied,materials science, textiles
Dna Binding And Photocleavage Properties, Cellular Uptake And Localization, And In-Vitro Cytotoxicity Of Dinuclear Ruthenium(Ii) Complexes With Varying Lengths In Bridging Alkyl Linkers

Ping Liu,Bao-Yan Wu,Jin Liu,Yong-Cheng Dai,You-Jun Wang,Ke-Zhi Wang

DOI: https://doi.org/10.1021/acs.inorgchem.5b01934

IF: 4.6

2016-01-01

Inorganic Chemistry

Abstract:Two new dinuclear Ru(II) polypyridyl complexes containing three and ten methylene chains in their bridging linkers are synthesized and characterized. Their calf thymus DNA-binding and plasmid DNA photocleavage behaviors are comparatively studied with a previously reported, six-methylene-containing analog by absorption and luminescence spectroscopy, steady-state emission quenching by [Fe(CN)(6)](4-), DNA competitive binding with ethidium bromide, DNA viscosity measurements, DNA thermal denaturation, and agarose gel electrophoresis analyses. Theoretical calculations applying the density functional theory (DFT) method for the three complexes are also performed to understand experimentally observed DNA binding properties. The results show that the two complexes partially intercalate between the base pairs of DNA. Cellular uptake and colocalization studies have demonstrated that the complexes could enter HeLa cells efficiently and localize within lysosomes. The in-vitro antitumor activity against HeLa and MCF-7 tumor cells of the complexes are studied by MTT cytotoxic analysis. A new method, high-content analysis (HCA), is also used to assess cytotoxicity, apoptosis and cell cycle arrest of the three complexes. The results show that the lengths of the alkyl linkers could effectively tune their biological properties and that HCA is suitable for rapidly identifying cytotoxicity and can be substituted for MTT assays to evaluate the cell cytotoxicity of chemotherapeutic agents.
[Is it possible to operate on noncompensated hyperfunctioning goiter?].

K. Czyżewski,F. Bielicki,Z. Zagrobelny

1968-12-06

Abstract:
Exploring the Cytotoxicity of Dinuclear Ru(II) p-cymene Complexes Appended N,N'-Bis(4-substituted benzoyl)hydrazines: Insights into the Mechanism of Apoptotic Cell Death

Abirami Arunachalam,Devan Umapathy,Ramesh Rengan,Antony Joeph Velanganni Arockiam,Jan Grzegorz Małecki

DOI: https://doi.org/10.1039/d3dt04234k

IF: 4

2024-02-14

Dalton Transactions

Abstract:Cancer is a perilous life-threatening disease, and attempts are constantly made to create multinuclear transition metal complexes that could lead to potential anticancer medications and administration procedures. Hence, this work aims to design, synthesize, characterize, and assess the anticancer efficacy of ruthenium p-cymene complexes incorporating N, N'- bis(4-substituted benzoyl)hydrazine ligands. The formation of the new complexes (Ru2H1-Ru2H3) has been thoroughly established by elemental analysis, FT-IR, UV-vis, NMR, and HR-MS spectral techniques. The solid-state molecular structures of the complexes Ru2H1 and Ru2H3 have been determined using the SC-XRD study, which confirms the N, O, and Cl-legged piano stool pseudo-octahedral geometry on each ruthenium(II) ion. The stability of these complexes in the solution state and their lipophilicity profile have been determined. Further, the titled complexes were tested for their in vitro anticancer activity against the cancerous H460 (lung cancer cells), SkBr3 (breast cancer cells), HepG2 (liver cancer cells), and Hela (cervical cancer cells) along with non-cancerous (HEK-293) cells. The IC50 results revealed that complex Ru2H3 exhibits potent activity against the proliferation of all four cancer cells and outscored the effect of standard metallodrug cisplatin. This may be attributed to the presence of a couple of lipophilic electron-donating methoxy groups in the ligand scaffold and also the ruthenium(II) p-cymene motifs. Advantageously, all the complexes (Ru2H1-Ru2H3) displayed cytotoxic specificity only towards the cancerous cell by leaving the off-target non-cancerous cells undamaged. Acridine orange/ethidium bromide (AO/EB) staining, Hoechst 33342, Mitochondrial Membrane Potential (MMP), and Reactive Oxygen Species (ROS) staining assays were used to investigate the apoptotic pathway and ROS levels in mitochondria. The results of Western blot analysis confirmed that complexes triggered apoptosis through intrinsic mitochondrial pathway by upregulating Bax and downregulating Bcl-2 proteins. Finally, the extent of apoptosis triggered by complex (Ru2H3) was quantified with the aid of flow cytometry using the Annexin V-FITC/propidium iodide (PI) double-staining technique.

chemistry, inorganic & nuclear
Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation

Mohamed M. Aboelnga,Heba A. Sahyon,Shadia A. Elsayed

DOI: https://doi.org/10.1002/aoc.7427

IF: 3.9

2024-03-14

Applied Organometallic Chemistry

Abstract:Ruthenium (III) anticancer candidates have been synthesized and characterized experimentally and theoretically. Their binding affinity toward biomacromolecules, in vitro anticancer activity, apoptosis, cell cycle and gene expression, and molecular docking have been explored. Ruthenium (III) complexes (1–3) of 2‐aminopyrazine (pyz) with general formula of [Hpyz][RuCl4(DMSO)(pyz)](1), Na[RuCl4(pyz)(DMSO)] (2), and (Hpyz)[RuCl4(pyz)2].2H2O (3) have been synthesized and characterized by elemental analyses, FTIR, 1H NMR, and UV–visible spectroscopy, along with the magnetic susceptibility and cyclic voltammetry measurements. The molecular structures of the complexes have also been optimized using density functional theory (DFT) calculation which demonstrates an octahedral geometry to be adopted by the Ru(III) ion. The UV–visible and fluorescence spectra were employed to study the interaction of the compounds with nucleic acid (ctDNA and tRNA) and bovine serum albumin (BSA). The data showed a higher tendency for the ligand and its complexes (1–3) to interact with biomolecules (1 > 2 > 3). All complexes showed potent in vitro anticancer activity against three human cancer cell lines and high safety against normal cell lines as complex (1) is the most active one, it was selected for the flow cytometric evaluation for cell death mode, cell cycle analysis, and matrix metalloproteinase‐9 (MMP9) expression in treated MDA‐231 cells. Proliferating cell nuclear antigen (PCNA) expression and VEGF concentration were evaluated in the treated cells and compared with the untreated ones. Our study proved that complex (1) arrests the cell cycle, inhibits DNA transcription, reduces both MMP9 (validated by our molecular docking investigation targeting MMP9 protein) and PCNA expressions, and induces apoptotic cell death, leading to cancer metastasis prevention.

chemistry, inorganic & nuclear, applied
Mononuclear η6-arene ruthenium(II) complexes with pyrazolyl-pyridazine ligands: synthesis, CT-DNA binding, reactivity towards glutathione, and cytotoxicity

Amos K Kanyora,Reinner O Omondi,Peter Ongoma,Josiah O Omolo,Athi Welsh,Sharon Prince,Joel Gichumbi,Allen Mambanda,Gregory S Smith

DOI: https://doi.org/10.1007/s00775-024-02043-3

Abstract:Organometallic η6-arene ruthenium(II) complexes with 3-chloro-6-(1H-pyrazol-1-yl)pyridazine (Ru1, Ru2, and Ru5) and 3-chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine (Ru3-4) N,N' heterocyclic and η6-arene (cymene (Ru1-4) or toluene (Ru 5)) have been synthesized. The ruthenium(II) complexes have common "three-legged piano-stool" pseudo-octahedral structures known for half-sandwich complexes. Evolution of their UV-Visible absorption spectra in PBS buffer or DMSO over 24 h confirmed their good solvolysis stability. Titrations of the complexes with the calf thymus DNA (CT-DNA) were monitored using UV-Visible absorption and fluorescence spectroscopies. The complexes interact moderately with CT-DNA and their binding constants are in the order of 104 M-1. Competitive binding of the complexes to a DNA-Hoechst 33,258 depicted competitive displacement of Hoechst from DNA's minor grooves. These complexes bind to glutathione forming GSH-adducts through S coordination by replacement of a halide, with the iodo-analogues having higher binding constants than the chloro-complexes. Cyclic voltammograms of the complexes exhibited one electron-transfer quasi-reversible process. Trends in the molecular docking data of Ru1-5/DNA were similar to those for DNA binding constants. Of the five, only Ru1, Ru3 and Ru5 showed some activity (moderate) against the MCF-7 breast cancer cells with IC50 values in the range of 59.2-39.9 for which Ru5 was the most active. However, the more difficult-to-treat cell line, MDA-MB 231 cell was recalcitrant to the treatment by these complexes.
Ru(II)‐Nitrophenylhydrazine/Chlorophenylhydrazine Complexes: Nanoarchitectonics, Biological Evaluation and In silico Study

Thomas Eichhorn,Marko Đošić,Dušan Dimić,Ibrahim Morgan,Dejan Milenković,Robert Rennert,Ana Amić,Zoran Marković,Goran N Kaluđerović,Jasmina Dimitrić Marković

DOI: https://doi.org/10.1002/ejic.202300683

IF: 2.551

2024-03-23

European Journal of Inorganic Chemistry

Abstract:Ru(II)‐arene compounds are being investigated as anticancer agents due to the biocompatibility of ruthenium and their structural diversity. Two newly synthesized Ru(II) complexes, [RuCl(η6‐p‐cymene)(3‐DNPH)] chlorido(η6‐p‐cymene)(k2‐N,N'‐3‐nitrophenylhydrazine) (1) and [RuCl(η6‐p‐cymene)(3‐CNPH)] chlorido(k2‐N,N'‐3‐chlorophenylhydrazine)(η6‐p‐cymene) (2), are experimentally (IR, NMR) and theoretically (B3LYP/6‐31+G(d,p)(H,C,N,Cl)/LanL2DZ(Ru)) characterized. Experimental and theoretical values of 1H and 13C chemical shifts and position of the most intense vibrational bands showed high correlation coefficients and low mean absolute errors, proving the predicted structure and applicability of the selected level of theory. Cell viability studies performed on MDA‐MB‐468, BT‐474, and PC3 cells using MTT and CV assay indicated the activity of the second complex similar to the activity of cisplatin towards BT‐474 breast cancer cells. The spectrofluorimetric measurements of Bovine Serum Albumin showed the binding process's spontaneity of complexes and protein, with a binding energy of around ‐30 kJ mol‐1. Detailed molecular docking analysis allowed the elucidation of the binding mechanism through specific intermolecular interactions. Both compounds showed a higher affinity towards BSA than naproxen and cisplatin. Molecular docking simulations proved the spontaneity of the complexes binding to DNA. Based on these promising results, further biological examinations of these compounds are advised.

chemistry, inorganic & nuclear

Fluorescence cystoscopy: is flexible scope as effective as rigid?

Ruthenium(II) Complexes with 2-Phenylimidazo[4,5-f][1,10]phenanthroline Derivatives that Strongly Combat Cisplatin-Resistant Tumor Cells

Syntheses, Characterization and Antitumor Activity of Three Mononuclear Ruthenium(II) Complexes

Systematic evaluation of the antitumor activity of three ruthenium polypyridyl complexes

Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine-Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties

New organoruthenium compounds with pyrido[2′,3′:5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action

Phenanthrene Appending Ruthenium Complexes: DNA Binding, Molecular Docking, TDDFT Calculation, and Photocytoxicity In Vitro

Synthesis, DNA-binding, molecular docking and cytotoxic activity in vitro evaluation of ruthenium(II) complexes

Synthesis, characterization, and anticancer activity of dithiocarbamate ruthenium(II) complexes

Synthesis, DNA Binding Mode, Singlet Oxygen Photogeneration and DNA Photocleavage Activity of Ruthenium Compounds with Porphyrin-Imidazo[4,5-f ]phenanthroline Conjugated Ligand

Photoinduced DNA Cleavage and Photocytotoxic of Phenanthroline-Based Ligand Ruthenium Compounds

DNA Interaction, DNA Photocleavage, Photocytotoxicity In Vitro, and Molecular Docking of Naphthyl-Appended Ruthenium Complexes

High-performance liquid chromatography of the aromatase inhibitor, letrozole, and its metabolite in biological fluids with automated liquid-solid extraction and fluorescence detection.

Dinuclear arene ruthenium(II) arylthiourea complexes: Synthesis, structure, cancer cell growth inhibition and apoptosis induction studies

Fortuitous synthesis of unsaturated half-sandwich Ruthenium(II) complexes via solvent-involved rearrangement and their biological evaluation

Dna Binding And Photocleavage Properties, Cellular Uptake And Localization, And In-Vitro Cytotoxicity Of Dinuclear Ruthenium(Ii) Complexes With Varying Lengths In Bridging Alkyl Linkers

[Is it possible to operate on noncompensated hyperfunctioning goiter?].

Exploring the Cytotoxicity of Dinuclear Ru(II) p-cymene Complexes Appended N,N'-Bis(4-substituted benzoyl)hydrazines: Insights into the Mechanism of Apoptotic Cell Death

Synthesis and characterization of novel Ru(III) complexes of 2‐aminopyrazine: Interaction with biomolecules, antineoplastic activity, and computational investigation

Mononuclear η6-arene ruthenium(II) complexes with pyrazolyl-pyridazine ligands: synthesis, CT-DNA binding, reactivity towards glutathione, and cytotoxicity

Ru(II)‐Nitrophenylhydrazine/Chlorophenylhydrazine Complexes: Nanoarchitectonics, Biological Evaluation and In silico Study